Cargando…

Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation

Persister cell formation and biofilms of pathogens are extensively involved in the development of chronic infectious diseases. Eradicating persister cells is challenging, owing to their tolerance to conventional antibiotics, which cannot kill cells in a metabolically dormant state. A high frequency...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xing, Zhou, Jiacheng, Richey, Gabriella, Wang, Mengya, Hong, Sung Min Choi, Hong, Seok Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Microbiology and Biotechnology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513074/
https://www.ncbi.nlm.nih.gov/pubmed/33046677
http://dx.doi.org/10.4014/jmb.2008.08027
_version_ 1784583145279979520
author Jin, Xing
Zhou, Jiacheng
Richey, Gabriella
Wang, Mengya
Hong, Sung Min Choi
Hong, Seok Hoon
author_facet Jin, Xing
Zhou, Jiacheng
Richey, Gabriella
Wang, Mengya
Hong, Sung Min Choi
Hong, Seok Hoon
author_sort Jin, Xing
collection PubMed
description Persister cell formation and biofilms of pathogens are extensively involved in the development of chronic infectious diseases. Eradicating persister cells is challenging, owing to their tolerance to conventional antibiotics, which cannot kill cells in a metabolically dormant state. A high frequency of persisters in biofilms makes inactivating biofilm cells more difficult, because the biofilm matrix inhibits antibiotic penetration. Fatty acids may be promising candidates as antipersister or antibiofilm agents, because some fatty acids exhibit antimicrobial effects. We previously reported that fatty acid ethyl esters effectively inhibit Escherichia coli persister formation by regulating an antitoxin. In this study, we screened a fatty acid library consisting of 65 different fatty acid molecules for altered persister formation. We found that undecanoic acid, lauric acid, and N-tridecanoic acid inhibited E. coli BW25113 persister cell formation by 25-, 58-, and 44-fold, respectively. Similarly, these fatty acids repressed persisters of enterohemorrhagic E. coli EDL933. These fatty acids were all medium-chain saturated forms. Furthermore, the fatty acids repressed Enterohemorrhagic E. coli (EHEC) biofilm formation (for example, by 8-fold for lauric acid) without having antimicrobial activity. This study demonstrates that medium-chain saturated fatty acids can serve as antipersister and antibiofilm agents that may be applied to treat bacterial infections.
format Online
Article
Text
id pubmed-8513074
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Society for Microbiology and Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-85130742021-10-13 Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation Jin, Xing Zhou, Jiacheng Richey, Gabriella Wang, Mengya Hong, Sung Min Choi Hong, Seok Hoon J Microbiol Biotechnol Research article Persister cell formation and biofilms of pathogens are extensively involved in the development of chronic infectious diseases. Eradicating persister cells is challenging, owing to their tolerance to conventional antibiotics, which cannot kill cells in a metabolically dormant state. A high frequency of persisters in biofilms makes inactivating biofilm cells more difficult, because the biofilm matrix inhibits antibiotic penetration. Fatty acids may be promising candidates as antipersister or antibiofilm agents, because some fatty acids exhibit antimicrobial effects. We previously reported that fatty acid ethyl esters effectively inhibit Escherichia coli persister formation by regulating an antitoxin. In this study, we screened a fatty acid library consisting of 65 different fatty acid molecules for altered persister formation. We found that undecanoic acid, lauric acid, and N-tridecanoic acid inhibited E. coli BW25113 persister cell formation by 25-, 58-, and 44-fold, respectively. Similarly, these fatty acids repressed persisters of enterohemorrhagic E. coli EDL933. These fatty acids were all medium-chain saturated forms. Furthermore, the fatty acids repressed Enterohemorrhagic E. coli (EHEC) biofilm formation (for example, by 8-fold for lauric acid) without having antimicrobial activity. This study demonstrates that medium-chain saturated fatty acids can serve as antipersister and antibiofilm agents that may be applied to treat bacterial infections. Korean Society for Microbiology and Biotechnology 2021-01-28 2020-10-13 /pmc/articles/PMC8513074/ /pubmed/33046677 http://dx.doi.org/10.4014/jmb.2008.08027 Text en Copyright © 2021 by The Korean Society for Microbiology and Biotechnology https://creativecommons.org/licenses/by/4.0/This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research article
Jin, Xing
Zhou, Jiacheng
Richey, Gabriella
Wang, Mengya
Hong, Sung Min Choi
Hong, Seok Hoon
Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation
title Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation
title_full Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation
title_fullStr Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation
title_full_unstemmed Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation
title_short Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation
title_sort undecanoic acid, lauric acid, and n-tridecanoic acid inhibit escherichia coli persistence and biofilm formation
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513074/
https://www.ncbi.nlm.nih.gov/pubmed/33046677
http://dx.doi.org/10.4014/jmb.2008.08027
work_keys_str_mv AT jinxing undecanoicacidlauricacidandntridecanoicacidinhibitescherichiacolipersistenceandbiofilmformation
AT zhoujiacheng undecanoicacidlauricacidandntridecanoicacidinhibitescherichiacolipersistenceandbiofilmformation
AT richeygabriella undecanoicacidlauricacidandntridecanoicacidinhibitescherichiacolipersistenceandbiofilmformation
AT wangmengya undecanoicacidlauricacidandntridecanoicacidinhibitescherichiacolipersistenceandbiofilmformation
AT hongsungminchoi undecanoicacidlauricacidandntridecanoicacidinhibitescherichiacolipersistenceandbiofilmformation
AT hongseokhoon undecanoicacidlauricacidandntridecanoicacidinhibitescherichiacolipersistenceandbiofilmformation